Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Chlamydia”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 937 records · Page 52Linked to original sources

[Chlamydia-induced reactive arthritis--HLA-B 27 negative two patients].

Two cases with HLA-B 27 negative, Chlamydia-induced reactive arthritis (ReA) were described. Case 1: A 30 y.o. male developed balanitis, urethritis, arthritis of both knees, elbows, shoulders and hip joints on May in 1997. Laboratory findings revealed CRP 2.7 mg/dl (normal range < 0.3), ESR 33 mm/h and negative rheumatoid factor (RF) test. Anti-Chlamydia trachomatis antibodies, IgG 2.22, IgA 3.33 were positive. HLA-typing revealed A 2, A 24 (9), B 39 (16), B 52 (5). He was diagnosed as ReA and arthritis subsided with treatment of minocycline and nonsteroidal antiinflammatory drugs (NSAIDs). Case 2: A 40 y.o. Iranian American male developed balanitis, urethritis, lumbago, arthritis of both elbows, knees and foot joints, iridocyclitis on August in 1995. Chlamydia trachomatis was detected in the urethral swab culture. He was diagnosed as ReA and treated with minocycline and NSAIDs. He was referred to our hospital on June in 1996. Arthritis at both knees and feet was detected. Laboratory findings revealed CRP 0.8 mg/dl, negative RF test was revealed. Antibodies to Chlamydia were positive (IgG 1.49, IgA 1.53) positive. HLA typing revealed A 1, A 2, B 37, B 55 (22). He was again treated with minocycline and NSAIDs and ReA ameliorated. Since HLA-B 22, B 37 and B 39 have been reported to cross-react or to have homology with B 27, B 22, B 37 and B 39 are likely to related to inducing ReA.

Adult↗

[Epidemiological study of Chlamydia trachomatis infection in a sample of women requesting voluntary termination of pregnancy, treated with rokitamycin].

BACKGROUND: Infection with Chlamydia trachomatis usually involves the cervix uteri, causing no symptoms, and may easily be unrecognised and untreated until troublesome symptoms arise, such as pelvic inflammatory disease, which can affect fertility and reproductive life. Therapies include the macrolide antibiotics, and in this class rokitamycin offers marked lipophilia, excellent intracellular penetration, and bactericidal activity at concentrations close to the MIC. The present study was therefore designed to establish the frequency of intracervical infection with Chlamydia trachomatis in women applying for termination of pregnancy, and to assess the efficacy and safety of this drug in this indication. METHODS: Women aged 18-40 years were admitted for termination of pregnancy, with a positive cervical swab for Chlamydia trachomatis. The study was conducted in accordance with the Declaration of Helsinki and amendments. Patients were given one oral tablet of 400 mg rokitamycin in the morning, and one in the evening, for two weeks. Treatment started ten days before the termination, within 48 h of taking the swab. Partners were to receive the same treatment. RESULTS: 292 women requiring termination of pregnancy, on average at the 9th week of pregnancy, were assessed. Of these, 24 (8.2%), mean (+/- SD) age 27.1 +/- 6.1 years, range 18-39, with a positive cervical swab for Chlamydia trachomatis, were treated with rokitamycin; 22 of their partners were treated too. Forty days after the start of treatment 22 patients (92%) gave negative results; these were all the cases whose partners had received treatment. No adverse events were reported and the acceptability of the treatment was considered good or excellent in 91% and fair in 9% of the cases. CONCLUSIONS: The findings confirm that rokitamycin is one of the most useful and effective macrolides for the treatment of infections caused by intracellular microorganisms; it is extremely well tolerated and has marked microbiological efficacy.

Abortion, Therapeutic↗

Application of polymerase chain reaction for the identification of generalized Chlamydia infection.

The authors draw attention to the possibility that some of the equivocal cases of internal diseases diagnosed variously and treated in various hospitals may actually be caused by Chlamydia trachomatis or other species of the genus Chlamydia. We report a case of a generalized chlamydia infection which brought about multiple lesions. The etiologic differentiation of the disorder in the present case was made possible only through using the method of polymerase chain reaction to identify the Chlamydia trachomatis agent.

Adult↗

Routine screening for Chlamydia trachomatis in subfertile women--is it time to start?

UNLABELLED: Genital Chlamydia trachomatis infection has long been recognised as the major cause of pelvic disease and subsequently infertility. The diagnosis of this infection has traditionally relied on tissue culture. The availability of DNA amplification methods like ligase chain reaction promises faster and more sensitive results. This study was conducted to evaluate the prevalence of chlamydial infection in a subfertile population subgroup. AIM: A case control longitudinal study of 100 subfertile women in a tertiary teaching hospital were analyzed for the prevalence of genital Chlamydia trachomatis infection using ligase chain reaction test kit. RESULTS: A prevalence rate of 8% was detected, the majority being 25 years old or less (33.3%), p = 0.007. All patients gave no prior history of abnormal PAP smears, hospitalisation for pelvic inflammatory disease or abnormal vaginal discharge at the time of investigation. CONCLUSION: Our infertile group of patients has a relatively high incidence of silent genital Chlamydia trachomatis infection. This being highest in the below 25 years old age group. This finding indicates that screening for chlamydia may be necessary for the subfertile couple presenting to clinic. This is especially so if the patient is of the younger age group.

Adult↗

Chlamydia trachomatis detection--is it doctor dependent?

The accuracy of tests for chlamydia depends, among other things, upon the quality of the clinical specimen. Most chlamydia tests do not allow comment on specimen quality. It has been shown that examination of Papanicolaou stains or Diff-Quik stains of endocervical secretions can be used to assess the quality of endocervical sampling. This study has found that by analysing surrogate markers, such as the rates of inadequate cervical cytology and chlamydia detection rates in patients not identified as chlamydia contacts, it is possible to identify doctors performing less well in cervical sampling without the need for extra tests.

Chlamydia Infections↗

Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.

OBJECTIVE: To determine the potential for both Pap testing and the Chlamydia direct fluorescence assay (DFA) from a single sample using the fluid-based ThinPrep Pap Test method (Cytyc Corporation, Boxborough, Massachusetts). STUDY DESIGN: Conventional DFA was compared to ThinPrep DFA in a direct-to-vial, double-blinded, multicenter protocol. Cervical scrapings were collected for the ThinPrep Pap Test, and then a second swab was used to collect an endocervical sample for a conventional DFA test. The DFA slide prepared from the ThinPrep Test and the conventional DFA sample prepared from the endocervical swab were evaluated independently. Discrepant cases were adjudicated by testing residual specimens using a Chlamydia direct DNA method. RESULTS: Combining 636 adequate cases (94% of the total collected), 582 (91.5%) were negative on both slides, 43 (6.8%) positive by both and 11 (1.7%) discrepant. The prevalence of Chlamydia was 7.9% based on the conventional DFA method (range, 4.3-10.9%). McNemar's two-tailed test indicated the results not to be statistically different (P > .05). Adjudication favored ThinPrep 45% of the time and conventional 55%. Specimen adequacy favored ThinPrep with high statistical significance (McNemar's test, P > .01). CONCLUSION: A second slide prepared from the same vial of cells as that used for the ThinPrep Pap Test can be used for Chlamydia testing by DFA. Fluid-based collection could allow multiple tests from a single sample.

Adolescent↗

The 'real-world' impact of improved diagnostic techniques for Chlamydia trachomatis infection in Glasgow.

In April 1997, the main chlamydia laboratory in Glasgow introduced ligase chain reaction (LCR) as its standard diagnostic test. The diagnostic effectiveness and health economic impact of introduction of LCR testing was assessed. Between April 1996 to March 2000, results of all chlamydia detection tests on genital specimens sent from general practitioners and the two main sexual healthcare providers (Genitourinary Medicine and Family Planning services) were reviewed. A preliminary economic assessment, inclusive of staff, reagents, consumables and laboratory overheads was conducted. Overall, testing activity increased four and a half times between 1996-97 and 1999-2000; the proportionate rise was greatest in general practice. Although chlamydia testing in both genders increased over the review period, testing activity rose disproportionately in women (59%, compared with a 31% increase in men). The overall Chlamydia trachomatis detection rate rose from 4.8% in 1996-97 to 7.8% in 1999-2000. Following introduction of LCR testing, an estimated additional 331 men and 844 women were diagnosed during the study period. The cost per additional diagnosis made was estimated at 162 Pounds for men and 263 Pounds for women. Substantial health gains are likely to be achieved, at both an individual and public health level, as a result of introduction of LCR testing for genital chlamydial infection.

Adolescent↗

Urogenital infection and seminal excretion after inoculation of bulls and rams with chlamydiae.

Five mature rams and 4 bulls were inoculated parenterally with bovine or ovine chlamydial strains of type 1 and 2. One to 3 days later, all animals developed a chlamydemia lasting 4 to 8 days. Chlamydial agents were isolated from the semen near the end of the chlamydemic phase. All rams and 3 of 4 inoculated bulls excreted chlamydiae in the semen for 22 to 29 days. From 8 to 39 days after inoculation, selected rams or bulls were killed to test for chlamydial infection in the urogenital tract and other organs. Chlamydiae were isolated in developing chicken embryos from testis, epididymis, and accessory sex glands. Bulls examined 29 and 39 days after inoculation did not harbor chlamydiae. Chlamydiae were also not isolated from 3 control bulls which were from the same herd as the principal bulls. All inoculated bulls and rams had a group-specific chlamydial antibody response within 7 days. The titers reached maximal levels of 128 to 512 at 14 days after inoculation. Subsequently, the antibody titers decreased gradually. Seminal plasma collected at different times after animals were inoculated did not fix complement in the presence of chlamydial group antigen. The number of polymorphonuclear leukocytes in the semen increased during the experiment. The semen was grossly purulent in 2 rams inoculated with the type 2 chlamydial strain of polyarthritis.

Animals↗

[Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].

OBJECTIVE: To investigate the infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis. METHODS: The identification and susceptibility of Neisseria gonorrhoeaes and Mycoplasmas were detected by a cultural method. The nitrocefin test was used to detect the beta-lactamase in Neisseria gonorrhoeae strains. Chlamydia trachomatis was identificated by a monoclonal gold labeled antibody method. RESULTS: A total of 2,900 prostatic fluids were detected and the rates of isolation of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis were 3.3%, 12.8%, and 0.9%, respectively. The prevalence of beta-lactamase in Neisseria gonorrhoeae strains was 12.6%. The resistant percentages of Neisseria gonorrhoeae strains were 73.7% to penicillin and 91.6% to ciprofloxacin and ofloxacin respectively, but the susceptibility to spectinomycin, cephalosporin and cefoxitin was good. The resistant rates of Mycoplasma to tetracycline, acetylspiramycin, erythromycin, and ofloxacin were 50.0% or more, but the susceptibilities to roxithromycin, doxycyclin, levofloxacin, minocyclin, josamycin, and azithromycin were about 70.0%-80.0%. CONCLUSION: The isolation rate of Mycoplasma is higher than that of Neisseria gonorrhoeae and Chlamydia trachomatis in the chronic prostatitis. It is important to detect the susceptibility of Neisseria gonorrhoeae and Mycoplasma for the use of antibiotics in reason.

Adult↗

Challenge of Chlamydia research.

Chlamydia is an obligate intracellular bacterial pathogen that severely challenges the patience and creativity of all its investigators--even to the point that some investigators have forsaken this field for more productive and fertile areas of research. The two principal difficulties that touch every aspect of chlamydial research are (a) that chlamydiae only grow within eukaryotic host cells and (b) there are limited genetic approaches available. Despite these technical difficulties, the fundamental underlying problem has been the expectation that chlamydiae are similar to other bacteria (or, historically, viruses) and amenable to study from this perspective. However, this has often turned out not to be the case. Chlamydiae have shown themselves to be unique at many levels and thus represent a formidable, yet enticing, research challenge.

Animals↗

An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia.

Chlamydia trachomatis is currently the most common sexually transmitted disease in the United States. The prevalence in pregnant women ranges between 2% and 47%. It is well known that C trachomatis can be transmitted from the genital tract of an infected mother to her newborn infant, causing conjunctivitis or pneumonia or both, along with their longstanding complications. A review of the literature failed to show, however, conclusive evidence of transmission of infection to the newborn infant when the infant was born by cesarean section with intact amniotic membranes. We present a case of a young black woman with a history of chlamydia cervicitis during pregnancy whose infant was delivered by cesarean section because of failure to progress. She gave birth to a healthy term infant who developed ophthalmia neonatorum on the 3rd day of life. Examinations of conjunctival scrapings with direct fluorescent staining (chlamydia MicroTrak) performed on the 1st and 3rd day of life were positive. The initial test was performed because of the maternal history. The infant was mildly symptomatic at the time the study was repeated for confirmation. Our findings strongly suggest the possibility of either transmembrane or transplacental route of infection in the pathogenesis of neonatal chlamydia infection. Further study is needed to confirm this possibility.

Adult↗

[The role of diagnostic tests in the identification of Chlamydia trachomatis infection in reactive arthritis].

UNLABELLED: Reactive arthritis (ReA) is a sterile inflammation of the synovial membrane of one or more joints developing after urogenital or gastro-intestinal infection. The syndrome most frequently follows infection with Chlamydia trachomatis. Useful for the diagnosis can be the serological tests. At present there is the possibility to identify the specific antibodies (IgG, IgA, IgM) to Chlamydia trachomatis. The subject of the study was the group of 87 patients in age 19-78; 58 women and 29 men from whom urogenital smear and serum were tested. The control group were 30 people age 25-70 without rheumatological disorders. Chlamydia trachomatis was found in urogenital smear in 42 (48%), in 56 (64%) patients immunoglobulin IgG were positive, and immunoglobulin IgA in 16 (18%). The laboratory tests and clinical symptoms allow to make a diagnosis of ReA in 38 (43%) and possible ReA in 5 (5.7%) of patients. CONCLUSIONS: 1. There is no gold standard for the diagnosis of ReA. 2. None of the tests or the clinical symptoms alone are strong enough to make a definite diagnosis of ReA. 3. Tests to identify Chlamydia trachomatis, with respect of typical clinical symptoms are useful the diagnosis of ReA. 4. The diagnosis of ReA is most probable if we have typical clinical symptoms, clinical evidence of a preceding infection plus a positive result of serology or PCR plus positivity for HLA-B27.

Adult↗

[Chlamydia trachomatis infection in women using 2 family planning clinics].

OBJECTIVE: To determine the prevalence of Chlamydia trachomatis in women attending two family planning clinics in Merida, Yucatan, Mexico. MATERIAL AND METHODS: From January to December 1998, a cross-sectional study was conducted in 1,100 sexually active women between 15 and 45 years of age. Study subjects had not received antibiotic therapy for at least one month prior to their visit to the clinic. Endocervical samples were taken for bacterial detection with the enzymatic Wellcozyme immunoassay method. Data were analyzed using the Epi-Info program. Statistical analysis was conducted using the chi-squared test and prevalence ratios. RESULTS: Seventy four women were positive to Chlamydia trachomatis (6.7%). Almost 50% of those women were asymptomatic. No statistically significant differences were found between the group with Chlamydia and the group without it who had vulvar-vaginal symptoms. Cervical changes were more frequent in infected women. More positive cases of Chlamydia infection were found in oral contraceptive users (8.3%) than among non users (5.4%). CONCLUSIONS: Study results confirm the high prevalence of asymptomatic infections and emphasize the importance of timely diagnosis to avoid infection sequelae. The English version of this paper is available at:http://www.insp.mx/salud/index.html.

Adolescent↗

Acute lower respiratory tract infection due to Chlamydia species in children under five years of age.

BACKGROUND: The contribution of Chlamydia spp in respiratory tract infections in paediatric population from India has not been studied in detail. METHODS: Sixty children under five years of age who were admitted with acute lower respiratory tract infection during a one year period were investigated for Chlamydial aetiology of respiratory infection. Diagnosis was based on antigen detection by direct immunofluorescence (DIF) in throat swab along with anti-Chlamydial immunoglobulin G (IgG) antibody demonstration by solid phase enzyme immunoassay (EIA). RESULTS: Chlamydia spp antigen was detected in seven (11.6%) cases, C. pneumoniae in six (10%) and C. trachoniatis in one (1.6%). Chlamydia spp IgG antibody in serum was demonstrated in 24 (40%) cases, of which C. pneumoniae IgG was denconstrated in 18 (30%) cases. Taking the criteria of antigen detection (n=7) and high IgG antibody titre of > or = 1:512 (n=5) for a positive case, 12 (20%) children were found to be suffering from recent Chlamydial infection. CONCLUSION: Chlamydia spp plays a significant role in respiratory tract infections in Indian paediatric population. Diagnostic procedure like antigen detection in throat swab is rapid, less cumbersome and feasible and should be more widely used along with antibody demonstration to determine the aetiological agent early in the course of illness.

Acute Disease↗

[Detection of chlamydia trachomatis in urine, vulval and cervical swabs].

BACKGROUND: Increased testing rates for Chlamydia infection among young women can be achieved by more use of self-administered sampling methods. In this study, vulval swabs and urine are compared to conventional cervix samples. MATERIALS AND METHODS: Vulval swabs, urine and cervix samples from 541 young, healthy women were tested for Chlamydia by polymerase chain reaction technique. RESULTS: The prevalence of Chlamydia infection was 4.1% (22/541). The sensitivity (cervix 22/22, urine 21/22 and vulva 21/22) and specificity (no false negative results) were high for all sampling sites. INTERPRETATION: Urine samples or vulval swabs can replace conventional cervix swabs for the detection of Chlamydia.

Adolescent↗

[The role of chlamydia trachomatis and some other associated microorganisms in endocervicitis].

The objective of the study was to examine the prevalence of Chlamydia trachomatis as a causative agent in women with clinically manifested endocervicitis and to find the age group where Chlamydia trachomatis was most prevalent. 553 women sexually active women in reproductive ag with clinically manifested endocervicitis e were examined. Chlamydial infection by direct immmunofluorescence was found in 239 (43, 2%) About 75% of the patients with chlamydial infection were in the age group 20-29 years. The predominant part of these women had no other associated infection except Chlamydia trachomatis. Association of Chlamydia trachomatis with candida albicans-25, 10%, bacteria vaginosis 23, 53%, Trichomonas vaginalis in 7.53% in the women with cervicitis.

Adolescent↗

[Bacteriologic studies of aborted sheep fetuses with special reference to chlamydiae].

A total of 467 tissue specimens recovered from 165 aborted ovine fetuses were examined for chlamydiae microscopically and by means of cell culture. Chlamydiae were detected by microscope in 34 fetuses (20.6%) and by cell culture in 60 fetuses (36.4%). Of the 467 tissue specimens, 51 (10.9%) were microscopically positive, whereas chlamydiae were recovered from 181 specimens (38.8%) using the routine method of BGM cell culture. A total of 87 specimens of fetal organs was tested by the BGM cell culture technique and simultaneously by an enzyme amplified immunoassay to detect chlamydial antigen. Although not as sensitive as cell culture isolation, the ELISA has the advantage of rapidity and of detecting antigen from non-viable chlamydiae in sheep abortion material.

Abortion, Veterinary↗

[Routine screening for Chlamydia: is it sensible during pregnancy?].

610 pregnant patients were examined for evidence of Chlamydia trachomatis infection. Chlamydia trachomatis could be detected in 18 of these 610 patients. This results in a low prevalence rate of 3%; therefore, screening for Chlamydia trachomatis is not indicated in our pregnant population. Among the 18 chlamydia-positive patients we could not discover any risk factors that were associated with this infection. Because of the varied and sometimes silent course in affected patients, this special investigation should be used liberally in a variety of situations.

Adult↗